The Journal of community and supportive oncology最新文献

筛选
英文 中文
Qualitative assessment of organizational barriers to optimal lung cancer care in a community hospital setting in the United States 在美国社区医院环境中对最佳肺癌治疗的组织障碍进行定性评估
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0394
Satish K. Kedia
{"title":"Qualitative assessment of organizational barriers to optimal lung cancer care in a community hospital setting in the United States","authors":"Satish K. Kedia","doi":"10.12788/JCSO.0394","DOIUrl":"https://doi.org/10.12788/JCSO.0394","url":null,"abstract":"Lung cancer is a major public health challenge in the United States. It is the leading cause of cancer death in the United States, accounting for 27% of all cancer deaths, and it has an aggregate 5-year survival rate of 18%.1 Advances in diagnostic and treatment options are rapidly increasing the complexity of lung cancer care delivery, which involves multiple specialty providers and often cuts across health care institutions.2-4 Navigating the process of care while coping with the complexities of the illness can be overwhelming for both the patient and the caregiver.5 With increasing regulations and cost-cutting measures, the health care system in the United States can pose many challenges, especially for those dealing with catastrophic and life-threatening illnesses. Any barrier to accessing care often increases anxiety in patients, who are already trying to cope with the management of their disease.6-8 The concept of barriers to quality care (such as the receipt of timely and appropriate diagnostic and staging work-up and treatment selection according to evidence-based guidelines) is generally used in the context of improving health care management or prevention programs.9-13 Barriers might include high costs, transportation, distance, underinsurance, limited hours for access to care, patient sharing by physicians, and a lack of access to information about physicians’ recommendations.10,14-16 Such bar-","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66811227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Rare paraneoplastic dermatomyositis secondary to high-grade bladder cancer 罕见副肿瘤性皮肌炎继发于高级别膀胱癌症
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0386
Adam M. Kase, A. Swaika, X. Geiger, W. Tan
{"title":"Rare paraneoplastic dermatomyositis secondary to high-grade bladder cancer","authors":"Adam M. Kase, A. Swaika, X. Geiger, W. Tan","doi":"10.12788/JCSO.0386","DOIUrl":"https://doi.org/10.12788/JCSO.0386","url":null,"abstract":"The clinical presentation of bladder cancer typically presents with hematuria; changes in voiding habits such as urgency, frequency, and pain; or less commonly, obstructive symptoms. Rarely does bladder cancer first present as part of a paraneoplastic syndrome with an inflammatory myopathy. Inflammatory myopathies such as dermatomyositis have been known to be associated with malignancy, however, in a meta-analysis by Yang and colleagues of 449 patients with dermatomyositis and malignancy there were only 8 cases reported of bladder cancer.1 Herein, we report a paraneoplastic dermatomyositis in the setting of a bladder cancer.","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43760016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma 应用阿普雷平治疗一例微囊型附件癌患者顽固性瘙痒症
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/jcso.0354
Johanna S. Song
{"title":"Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma","authors":"Johanna S. Song","doi":"10.12788/jcso.0354","DOIUrl":"https://doi.org/10.12788/jcso.0354","url":null,"abstract":"Substance P is an important neurotransmitter implicated in itch pathways.1 After binding to its receptor, neurokinin-1 (NK-1), substance P induces release of factors including histamine, which may cause pruritus.2 Recent literature has reported successful use of aprepitant, an NK-1 antagonist that has been approved by the US Food and Drug Administration for the treatment of chemotherapy-induced nausea and vomiting, for treatment of pruritus. We report here the case of a patient with microcystic adnexal carcinoma (MAC) who presented with refractory pruritus and who had rapid and complete resolution of itch after administration of aprepitant.","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44044232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing communication between oncology care providers and patient caregivers during hospice 在临终关怀期间加强肿瘤护理提供者和患者护理人员之间的沟通
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0391
J. Bauman
{"title":"Enhancing communication between oncology care providers and patient caregivers during hospice","authors":"J. Bauman","doi":"10.12788/JCSO.0391","DOIUrl":"https://doi.org/10.12788/JCSO.0391","url":null,"abstract":"","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45374844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Gastrointestinal cancers: new standards of care from landmark trials 胃肠道癌症:里程碑式试验的新治疗标准
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0377
D. Henry
{"title":"Gastrointestinal cancers: new standards of care from landmark trials","authors":"D. Henry","doi":"10.12788/JCSO.0377","DOIUrl":"https://doi.org/10.12788/JCSO.0377","url":null,"abstract":"DR HENRY I am Dr David Henry, the Editorin-Chief of The Journal of Community and Supportive Oncology ( JCSO; JCSO-online. com). I’m with Dr Dan Haller, former Editor-inChief of the Journal of Clinical Oncology and currently the Editor-in-Chief of American Society of Clinical Oncology (ASCO) University. He is also my friend and former mentor at University of Pennsylvania Abramson Cancer Center, where he is Professor Emeritus. We’re going to talk about colorectal cancer and a lot of things that came out of the ASCO meeting this year that were practice changing, or certainly interesting and worth further discussion. I thought we’d start talking about the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) collaboration, in which for patients with colorectal cancer who were considering adjuvant postoperative therapy, there was a discussion of 3 cycles versus 6 cycles of FOLFOX (fluorouracil [5-FU] plus oxaliplatin) or XELOX (capecitabine plus oxaliplatin, also CAPOX) (Figure 1).1 Could you comment on what they did, and how that study turned out?","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48332926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated ocular metastases from lung cancer 癌症孤立性眼部转移
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0258
S. Varghese, M. Adnan, M. Khawandanah, Sam Dahrv, C. Kurkjian
{"title":"Isolated ocular metastases from lung cancer","authors":"S. Varghese, M. Adnan, M. Khawandanah, Sam Dahrv, C. Kurkjian","doi":"10.12788/JCSO.0258","DOIUrl":"https://doi.org/10.12788/JCSO.0258","url":null,"abstract":"Case presentation and summary A 60-year-old man with a 40-pack per year history of smoking presented to multiple ophthalmologists with complaints of decreased vision and redness of the left eye. He was eventually evaluated by an ophthalmologist who performed a biopsy of the anterior chamber of the eye. Histologic fi ndings were consistent with adenocarcinoma of lung primary (Figures 1 and 2). After the diagnosis, a chest X-ray showed that the patient had a left lower lung mass. Th e results of his physical exam were all within normal limits, with the exception of decreased visual acuity in the left eye. Th e results of his laboratory studies, including complete blood count and serum chemistries, were also within normal limits. Imaging studies – including a computed-tomography (CT) scan of the chest, abdomen, and pelvis and a full-body positron-emission tomography–CT scan – showed a hypermetabolic left lower lobe mass 4.5 cm and right lower paratracheal lymph node metastasis 2 cm with a small focus of increased uptake alone the medial aspect of the left globe (Figures 3 and 4). An MRI orbit was performed in an attempt to better characterize the left eye mass, but no optic lesion was identifi ed. A biopsy of the left lower lung mass was consistent with non–small-cell lung cancer (NSCLC). Aside from the isolated left eye metastases, the patient did not have evidence of other distant metastatic involvement.","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43158113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trastuzumab-dkst approval adds to the biosimilar cancer drug market Trastuzumab-dkst获批进入生物仿制抗癌药物市场
The Journal of community and supportive oncology Pub Date : 2018-03-01 DOI: 10.12788/JCSO.0398
J. D. Lartigue
{"title":"Trastuzumab-dkst approval adds to the biosimilar cancer drug market","authors":"J. D. Lartigue","doi":"10.12788/JCSO.0398","DOIUrl":"https://doi.org/10.12788/JCSO.0398","url":null,"abstract":"","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46780339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management. 血管内大b细胞淋巴瘤:难以捉摸的诊断和具有挑战性的管理。
The Journal of community and supportive oncology Pub Date : 2018-01-01 DOI: 10.12788/jcso.0425
Akash Mukherjee, Ibrahim F Ibrahim
{"title":"Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management.","authors":"Akash Mukherjee, Ibrahim F Ibrahim","doi":"10.12788/jcso.0425","DOIUrl":"https://doi.org/10.12788/jcso.0425","url":null,"abstract":"","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":"16 6","pages":"e280-e282"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518387/pdf/nihms-1034868.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38430084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States 转移性疾病患者骨折住院治疗:美国原发性病变
The Journal of community and supportive oncology Pub Date : 2017-12-01 DOI: 10.12788/JCSO.0385
Lucas E. Nikkel, Bilal Mahmood, Sarah T. Lander, Michael A. Maceroli, Edward J. Fox, W. Tyler, L. Karbach, J. Elfar
{"title":"Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States","authors":"Lucas E. Nikkel, Bilal Mahmood, Sarah T. Lander, Michael A. Maceroli, Edward J. Fox, W. Tyler, L. Karbach, J. Elfar","doi":"10.12788/JCSO.0385","DOIUrl":"https://doi.org/10.12788/JCSO.0385","url":null,"abstract":"It has been well established that metastatic disease to bone has major signi cance in the morbidity associated with the diagnosis of cancer.1 More than 75% of patients with metastatic cancer will have bone involvement at the time of death.2-4 Moreover, there is a reported 8% incidence of a pathologic fracture in patients who carry the diagnosis of cancer.5 Common sites of involvement include the spine, ribs, pelvis, and long bones such as humerus and femur.6 Pathologic fracture is fracture caused by disease rather than injury or trauma (referred to here as nonpathologic). In any bone, pathologic fracture will be associated with increased morbidity for the patient, but it is the spine and long bones that frequently require surgical intervention and are associated with high mortality and morbidity. Advanced cancer can also increase fracture risk through increasing falls; in one prospective study of patients with advanced cancer, more than half the patients experienced a fall.7 Based on historical studies of patients who have died from common cancers,4,6 it is commonly","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45489491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Balancing quality and cost of care with patient well-being 平衡护理质量和成本与患者福祉
The Journal of community and supportive oncology Pub Date : 2017-12-01 DOI: 10.12788/JCSO.0390
J. Abraham
{"title":"Balancing quality and cost of care with patient well-being","authors":"J. Abraham","doi":"10.12788/JCSO.0390","DOIUrl":"https://doi.org/10.12788/JCSO.0390","url":null,"abstract":"","PeriodicalId":75058,"journal":{"name":"The Journal of community and supportive oncology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47079448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信